Fraud Alerts / OIG Special Fraud Alerts / Special Fraud Alert_August 1994 / Prescription drug marketing schemes

Why This Topic Matters

It helps readers recognize that certain marketing arrangements tied to prescription drugs can create fraud-and-abuse exposure and affect reimbursement relationships. The alert is useful for compliance review, risk assessment, and policy awareness in healthcare organizations involved with drug products and beneficiary referrals.

Article Sections

1. Overview of the fraud alert

   Introduces the OIG alert and the broad compliance concerns associated with prescription drug marketing practices. It places the discussion in the context of federal health program reimbursement and provider relationships.

2. Why these marketing arrangements are risky

   Describes the general reasons the OIG viewed certain remuneration-based marketing activities as problematic. It addresses patient protection, provider judgment, and potential impact on federal program costs.

3. Examples of marketing activities identified by OIG

   Summarizes the categories of conduct the OIG used to illustrate the scope of the alert. The discussion is organized around representative industry practices involving providers, pharmacies, patients, and manufacturers.